Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGF Serum for Facial Skin Aging
NCT05724589Completed
- Sponsor
- St John's Institute of Dermatology
- Start
- Jan 2023
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of epidermal growth factor in Skin aging, sponsored by St John's Institute of Dermatology. Primary endpoints: Facial Skin Hydration at 16 weeks, Transepidermal Water Loss at 4 months and 4 more. Started Jan 2023; status: completed.
02
Drugs
epidermal growth factor
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT05724589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05724589.